ARTICLE | Clinical News
Tracleer bosentan regulatory update
February 26, 2001 8:00 AM UTC
The European Commission granted Orphan Medicinal Product designation to ATLN's Tracleer bosentan to treat pulmonary arterial hypertension. Last year the company received FDA Orphan Drug designation fo...